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Abstract
Astrocytes have recently become a major center of interest in
neurochemistry with the discoveries on their major role in brain
energy metabolism. An interesting way to probe this glial
contribution is given by in vivo 13C NMR spectroscopy coupled
with the infusion labeledglial-speciﬁcsubstrate,suchasacetate.
In this study, we infused alpha-chloralose anesthetized rats with
[2-13C]acetate and followed the dynamics of the fractional
enrichment (FE) in the positions C4 and C3 of glutamate and
glutamine with high sensitivity, using 1H-[13C] magnetic reso-
nance spectroscopy (MRS) at 14.1T. Applying a two-compart-
mentmathematicalmodel to themeasured time courses yielded
a glial tricarboxylic acid (TCA) cycle rate (Vg) of
0.27  0.02 lmol/g/min and a glutamatergic neurotransmis-
sion rate (VNT) of 0.15  0.01 lmol/g/min. Glial oxidative ATP
metabolism thus accounts for 38%of total oxidativemetabolism
measured by NMR. Pyruvate carboxylase (VPC) was
0.09  0.01 lmol/g/min, corresponding to 37% of the glial
glutamine synthesis rate. The glial and neuronal transmitoc-
hondrialﬂuxes(Vx
gandVx
n)wereof thesameorderofmagnitude
as the respective TCA cycle ﬂuxes. In addition, we estimated a
glial glutamate pool size of 0.6  0.1 lmol/g. The effect of
spectral data quality on the ﬂuxes estimates was analyzed by
Monte Carlo simulations.
Keywords: 13C MRS, acetate metabolism, glial TCA cycle,
glutamate/glutamine cycle, metabolic modeling, neurotrans-
mission.
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The brain, which is one of the most energy demanding
organs in mammals, is the center of a very complex neuronal
network which accomplishes the major part of the treatment
of sensory information and motor functions as well as a large
amount of cognitive functions, including memory, solving
problems and making decisions. All these cerebral functions
are the result of an intense electrochemical interaction
between two major cell types, neurons and glial cells. In
traditional neuroscience of the 20th century, the standard
picture of brain function was that the neurons accomplish the
numerous cerebral tasks, while the glial cells are simply
responsible to maintain the neuronal environment in good
conditions to enable proper neurotransmission. However,
several studies changed this conception and showed that glial
cells are active elements of the neurotransmission process
(Shank et al. 1993; Yudkoff et al. 1993). Glial cells are in
particular involved in the glutamate-glutamine cycle, where
they are responsible for the uptake of glutamate (the major
excitatory neurotransmitter) from the synaptic cleft and its
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conversion to the electrophysiologically inactive glutamine.
The maintenance of the neurotransmission processes requires
energy, delivered by glycolysis and the neuronal and glial
tricarboxylic acid (TCA) cycle from glucose, which is the
major energy substrate for the brain (Sokoloff 1977).
However, glial cells are also fueled by alternative substrates,
such as acetate (Badar-Goffer et al. 1990; Cerdan et al.
1990). More recent studies have shown evidences for the
particular versatile function of astrocytes in brain energy
metabolism; their capabilities to use a wide range of energy
substrates (McKenna 2012) and to adapt their metabolism
under pathological conditions (Gulanski et al. 2013; Jiang
et al. 2013). In vivo 11C-acetate infusion experiments also
showed an increased washout rate of the produced 11C-
labeled metabolites under neuronal activation, pointing to an
increase of astrocytic oxidative metabolism (Wyss et al.
2009), yet without demonstrating the quantitative relation-
ship between the washout rate and glial CMRO2. Recent
developments have been therefore undertaken to enable the
biochemical interpretation of 11C-acetate uptake curves
(Lanz et al. 2012). As a consequence, acetate might become
in the near future a substrate of choice to probe modiﬁcations
of glial energy metabolism in neurologic patients, insofar a
detailed biochemical understanding of the observed metab-
olite labeling is achieved.
Two-compartment modeling combined with dynamic 13C
magnetic resonance spectroscopy (MRS) has proven to be a
powerful tool to probe brain oxidative metabolism and
neurotransmission, both in human and rodent studies
(Gruetter et al. 2001; Henry et al. 2006). Most of these
studies used 13C labeled glucose as substrate to determine
neuroglial metabolic ﬂuxes (Gruetter et al. 2001; Choi et al.
2002; Henry et al. 2002; de Graaf et al. 2003a, 2004; Oz
et al. 2004; Duarte et al. 2011). Since glucose is metabo-
lized both in neurons and glial cells, the labeling of the
glutamate and glutamine carbon positions is reﬂecting a
mixture of the metabolic ﬂow through the glial and neuronal
TCA cycles. Depending on the number of measured turnover
curves and on the experimental conditions, some of the
determined metabolic ﬂuxes can be subject to high uncer-
tainties and might be unreliable as discussed by (Shestov
et al. 2007; Duarte et al. 2011). This issue was especially
raised for the glutamate-glutamine cycle ﬂux.
Acetate is speciﬁcally taken up by the glia (Waniewski and
Martin 1998) and thus is an ideal substrate to probe glial
oxidative metabolism and to potentially increase the sensi-
tivity of the measurement of the glutamate-glutamine cycle
(Araque et al. 1999; de Graaf et al. 2003b; Henry et al.
2006). When infusing 13C labeled acetate, glutamine
becomes the labeling precursor of the large neuronal
glutamate pool, whose turnover dynamics is therefore very
sensitive to the glutamatergic neurotransmission rate.
When infusing [2-13C]acetate, the ﬁrst amino acid position
to be labeled is the C4 of the small glial glutamate pool,
which quickly labels the C4 of glial glutamine. The transfer
of 13C to glial glutamate C4 is the result of two processes,
namely the activity of the glial TCA cycle (represented by
Vtca
g = Vg+VPC) and the tracer exchange between 2-oxoglut-
arate in the glial TCA cycle and the cytosolic glutamate
(represented by Vx
g). If only the positions C4 of glutamate
and glutamine are measured, metabolic modeling enables the
determination of the composite ﬂux Vgt
g [Vgt
g = Vx
g∙Vtcag/
(Vx
g+Vtca
g)], while assumptions on the exchange ﬂux Vx
g
have to be made to extract Vtca
g (Uffmann and Gruetter 2007;
Lanz et al. 2012).
Additional information on the individual values of the glial
TCA cycle rate and the glial exchange rate Vx
g requires the
measurement and mathematical modeling of the C3 enrich-
ment curves, similar to what was previously shown in one-
compartment brain metabolic modeling (Henry et al. 2006;
Uffmann and Gruetter 2007). The slope of the initial part of
the neuronal glutamate C3 turnover curve is indicative of the
Vx
n/Vtca
n ratio. In a similar way, the turnover of glial
glutamate C3 and its direct product glutamine C3 carries
information on the Vx
g/Vtca
g ratio. The simultaneous mea-
surement of the time course of the C4 and C3 positions of
glutamate and glutamine is therefore a necessary condition to
determine both TCA cycle ﬂuxes with minimal assumptions.
With infusion of 13C labeled acetate, the precision of the
estimated glial metabolic ﬂuxes is also expected to be higher
than with 13C glucose, where label incorporation into the
glutamate-glutamine cycle is heavily weighted by the strong
activity of the neuronal TCA cycle.
In all previous 13C MRS studies using 13C-acetate infusion
in rats, the 13C uptake curves of the labeling position C3 of
glutamate and glutamine could not be determined directly in
vivo, preventing the determination of the exchange rates Vx
g
and Vx
n. In some studies, the metabolic ﬂuxes were extracted
from data acquired at metabolic steady-state (Patel et al.
2005), which allows only the determination of relative
metabolic rates (ratios like VNT/Vtca
n). Other studies mea-
sured the glutamate and glutamine C3 enrichments ex vivo in
a separate group of animals, at limited time points (typically
one or two) (Patel et al. 2010) or using coinfusion of 13C
labeled glucose and acetate (Deelchand et al. 2009a), which
results in a higher NMR signal with a complex isotopomer
pattern, to which an extended metabolic modeling approach
needs to be developed (Shestov et al. 2012). Finally,
sequential infusion of 13C-labeled glucose and acetate in
two different animal groups were undertaken with a common
modeling (van Eijsden et al. 2010), where the steady-state
enrichment following [2-13C]acetate infusion was used as a
constraint for the modeling of the [U-13C]glucose dynamic
data.
The difﬁculty of acquiring dynamic labeling data directly
using 13C-acetate infusion is linked to the predominant glial
metabolism of acetate and the large inﬂow of unlabeled
carbons through the dominating neuronal TCA cycle, which
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results in a strong dilution of the labeling in glutamate and
glutamine and thus to a reduction of the measured 13C signal.
Not surprisingly, most in vivo 13C-acetate brain studies were
thus performed with indirect detected 13C NMR using the
related increased sensitivity (Deelchand et al. 2009b; Patel
et al. 2010). However, if indirect 13C detection enables a
signiﬁcant gain in sensitivity by measuring the protons
attached to the 13C nuclei, its intrinsically low spectral
resolution often makes it impossible to distinguish between
certain labeling positions, like the C3 resonances of gluta-
mate and glutamine.
The aim of this study was to take advantage of the
increased spectral resolution obtained at 14.1T (see Fig. 2a)
to measure in vivo and separately the turnover of the C4 and
C3 positions of glutamate and glutamine to assess neuroglial
metabolism, using an infusion of [2-13C]acetate. A major
objective was to determine the glial and neuronal transmi-
tochondrial exchange rates Vx
g and Vx
n. A second aim was to
use the high sensitivity of the turnover curves to determine
for the ﬁrst time the glial glutamate pool size in rat brain
tissue. Finally, Monte Carlo simulations were used to assess
the precision of the determined metabolic ﬂuxes and further
to investigate the evolution of this precision with changes in
the experimental conditions (experiment duration, SNR, and
temporal resolution).
Materials and methods
The metabolic modeling presented in this study is based on MRS
data previously acquired with a newly developed full signal
intensity 1H-[13C] NMR sequence (Xin et al. 2010). For complete-
ness sake, the animal preparation and NMR acquisition protocols are
brieﬂy described below.
Animal preparation
All animal experiments were approved by the veterinary authorities
of the Canton of Vaud and were performed in accordance with their
guidelines. The experiments were performed by licensed investiga-
tors. Six healthy male Sprague–Dawley rats (263  19 g,
mean  standard deviation, Charles River Laboratories, L’Arbresle,
France) were fasted overnight (15–16 h), with free access to water
before the studies. Animals were intubated and ventilated with 2%
isoﬂurane during the surgery. Both femoral veins were catheterized
for continuous infusion of a-chloralose (Fisher Scientiﬁc, Pitts-
burgh, PA, USA) and 99% enriched [2-13C]sodium acetate (Sigma-
Aldrich, St. Louis, MO, USA). One femoral artery was cannulated
for blood sampling. After preparation, anesthesia was achieved by
an 80 mg/kg initial bolus of a-chloralose, followed by continuous
infusion at a rate of ~26.7 mg/kg/h. The animal was placed in a
homemade holder and the head was stereotaxically ﬁxed. Respira-
tion rate and blood pressure were continuously monitored (SA
Instruments Inc., Stony Brook, NY, USA ). Body temperature was
measured by a rectal thermosensor and maintained at 38.0  0.5°C
by circulating heated water. A variable bolus of 3M 99% enriched
[2-13C]sodium acetate (pH = 6) was given over two consecutive 5-
min periods, with rates of 1.8 mmol/min/kg and 1.1 mmol/min/kg,
respectively, and then a continuous rate of 0.3 mmol/min/kg was
applied. The infused volume of acetate solution was ~5 mL in total.
Arterial blood (200 lL) was sampled approximately every 30 min
for monitoring blood gases (pCO2 = 39  2 mm Hg, pO2
> 100 mm Hg), pH (7.41  0.03), and the analysis of plasma
acetate concentration and isotopic enrichment, measured with high-
resolution NMR spectroscopy (Xin et al. 2010). An aliquot of
arterial blood was immediately centrifuged and stored in a nearby
80°C freezer for subsequent processing. The total amount of blood
withdrawn was below 10% of the total blood volume of the rat.
In vivo 13C MRS acquisition
All experiments were carried out on an animal magnetic resonance
imaging system (Varian, Palo Alto, CA, USA) interfaced to a 14.1
T, 26 cm, horizontal-bore magnet (Magnex Scientiﬁc, Oxford, UK)
with actively shielded gradients (12 cm inner diameter, 400 mT/m
in 120 ls). A homemade 13 mm diameter geometrically decoupled
quadrature 1H surface coil with a 10 mm diameter single-loop linear
13C coil was used as both transmitter and receiver. Fast spin-echo
images (effective TE = 45 ms, echo train length = 8, pulse repe-
tition time = 2.5 s, number of transitions = 2, slice thick-
ness = 1 mm, ﬁeld of view = 30 9 30 mm2, matrix = 256 9
256) were acquired for positioning of the volume of interest.
Localized 1H{13C} spectra were acquired from a volume of 144 lL
(8 9 3 9 6 mm3) centered in cerebral cortex of the rat brain. To
optimize the magnetic ﬁeld homogeneity in the volume of interest,
an echo-planar imaging version of FASTMAP (Gruetter and Tkac
2000) was used to adjust all ﬁrst- and second-order shims, which
achieved a full width at half maximum of the water signal of 20–
22 Hz in vivo. During 150 min of 99% enriched [2-13C]sodium
acetate infusion, 13C enrichment (GluC4, GlnC4, GluC3, GlnC3,
AceC2) and total concentration of glutamate, glutamine, and acetate
were acquired using the SPECIAL-BISEP 1H{13C} NMR sequence.
For a detailed description of this pulse sequence and the related
spectral quantiﬁcation, we refer the reader to our previously
published work (Xin et al. 2010).
Metabolic modeling
Metabolic modeling was developed based on the compartmentalized
neurotransmitter approach (Gruetter et al. 2001; Sibson et al. 2001).
Brain tissue is mainly composed of glial and neuronal cells. It is
now well established that glial cells are actively involved in
glutamate neurotransmission, for example, through the uptake of the
major excitatory neurotransmitter glutamate from the synaptic cleft
(Arriza et al. 1994; Rothstein et al. 1996; Hertz 2011). The model
therefore consists of two main metabolic compartments correspond-
ing to each type of cell. Each compartment consists of the respective
TCA cycle and both compartments are linked by the glutamate-
glutamine cycle, responsible for the neurotransmission.
Acetate has the particularity to be metabolized almost purely in
astrocytes (glial compartment) (Badar-Goffer et al. 1990; Hassel
et al. 1995; Waniewski and Martin 1998; Lebon et al. 2002). As a
consequence, the inﬂow of new 13C label from the substrate is
occurring through the glial TCA cycle. The neuronal TCA cycle
provides unlabeled carbons originating from neuronal pyruvate
metabolism to the glutamate-glutamine cycle. However, 13C ﬂow
from the carbon position 4 of glutamate to the position 3 occurs both
in the glial and neuronal compartment (see Appendix and Fig. 1b).
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The resulting model is presented in Fig. 1a. To illustrate how label
is transferred within a molecule in the TCA cycle, we added the
detailed scheme in Fig. 1b. 13C from [2-13C]acetate enters the glial
TCA cycle at the position 4 of citrate. In the ﬁrst turn of the TCA
cycle, 13C-reaches the position 4 of 2-oxoglutarate with a total net
ﬂux Kdil(Vg+VPC) (Appendix, eqn (10)), where Kdil represents the
afﬁnity of glial metabolism to acetate. Kdil was ﬁxed to 0.76, as
previously found in 13C in vivo brain studies using [1,6-13C2]
glucose infusion (Duarte et al. 2011). Similarly, in a previous 13C-
acetate infusion study (Deelchand et al. 2009b), it was estimated
that about 80% of acetyl-CoA entering the glial TCA cycle is
synthesized from [2-13C]acetate, while the remaining 20% is
synthesized from unlabeled glucose, in similar physiological
conditions. 2-oxoglutarate exchanges label with cytosolic glutamate.
This transmitochondrial label exchange, denoted by Vx
g, transfers
label from the carbon position 4 of 2-oxoglutarate to the position 4
of glutamate. As a result of the symmetry of the succinate molecule,
the second turn of the TCA cycle brings half of the labeled carbons
of the position 4 of 2-oxoglutarate to the position 3 of 2-oxoglutarate
and half to the position 2 of 2-oxoglutarate, further eliminated as
13CO2. Through the transmitochondrial ﬂux Vx
g, [3-13C]glutamate is
formed from [3-13C]2-oxoglutarate. Pyruvate carboxylase brings
unlabeled 12C from pyruvate to oxaloacetate, which further dilutes
the position C3 of glial glutamate. Pyruvate carboxylase is also
responsible to maintain the balance of mass in the glial TCA cycle
and compensates the label efﬂux from glutamine or contributes to a
possible accumulation in the amino acids concentrations.
When glutamate and glutamine total concentrations are constant
(metabolic steady-state), the mass balance is given by the following:
VGS ¼ VNT þ VPC ð1Þ Steady-state of glialglutamate
VGlu ¼ VNT ð2Þ Steady-state of neuronalglutamate
Vefflux ¼ VGS  VGlu ¼ VPC ð3Þ Steady-state ofglutamine
On the neuronal side, label entering the TCA cycle in the ﬁrst turn
from acetate is neglected, consistent with the glial-speciﬁc uptake of
acetate. Nevertheless, once neuronal glutamate is sufﬁciently labeled
by the action of the glutamate-glutamine cycle, the exchange
between glutamate and 2-oxoglutarate through Vx
n allows a labeling
of the glutamate at position 3 from the glutamate at position 4 in the
second turn of the TCA cycle, similar to what happens in the glial
TCA cycle [Appendix, eqn (23)].
A system of linear differential equations was derived for this two-
compartment model, assuming constant metabolic ﬂuxes. As
previously shown (Uffmann and Gruetter 2007), the temporal
change in labeling of the TCA intermediates present in low
concentration can be eliminated from the mathematical model
without modifying the labeling dynamics of glutamate, resulting in a
6-pools model (Glu4
g, Glu3
g, Gln4, Gln3, Glu4
n, Glu3
n). The
detailed derivation of the labeling equations is provided in the
appendix.
The NMR-measured brain AceC2 enrichment was ﬁtted by an
exponential function multiplied with a linear function, to take into
account the slow increase in AceC2 fractional enrichment (FE) in
the later part of the experiment (see Fig. 2b). The ﬁtted AceC2 curve
was used as direct input function for the metabolic system. The time
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Fig. 1 (a) Schematic view of the two-compartment model used to
describe the dynamic 13C MRS data acquired in the brain after [2-13C]
acetate infusion. Acetate is transported across the blood brain barrier
and is metabolized to acetyl-CoA, which enters the glial tricarboxylic
acid (TCA) cycle at the level of citrate. Vg is the TCA cycle rate in the
glia, Vtca
n the TCA cycle rate in the neuronal compartment. The
transmitochondrial exchange rates Vx
g and Vx
n model the exchange
between amino acids and 2-oxoglutarate, in the glial and neuronal
compartment, respectively. In the glial compartment, VPC represents
the pyruvate carboxylase, responsible for anaplerosis. VGS is the
glutamine synthesis ﬂux and VGlu summarizes the transport of
glutamine to the neurons and its conversion to glutamate. VNT is the
apparent glutamatergic neurotransmission rate. Finally, efﬂux of
labeling from the metabolic system occurs through the rate of glial
glutamine loss Vefﬂux. (b) Detailed view of the label scrambling from
[2-13C]acetate between the C4 and C3 positions of glutamate (Glu) in
the glial and neuronal TCA cycle. 13C enters in the glial compartment,
is incorporated in the glial TCA cycle and labels 2-oxoglutarate (OG) at
the position C4 in the ﬁrst turn of the TCA cycle. Through transmitoc-
hondrial transport, OG is in exchange with the cytosolic Glu which gets
labeled at the position C4. After the second turn of the glial TCA cycle,
OG C3 is labeled from OG C4. This labeling pathway is diluted by the
action of pyruvate carboxylase, bringing unlabeled carbons from
pyruvate to the position C3 of oxaloacetate. Through transmitochond-
rial, glial Glu C3 is labeled from OG C3. The neuronal TCA cycle acts
similarly, with the difference that no 13C from acetate enters the ﬁrst
turn of the TCA cycle and that pyruvate carboxylase is absent from the
neuronal compartment.
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courses of total glutamate and glutamine were ﬁtted with a linear
function and used in the modeling as constraints in the mass balance
equations. The two-compartment model was therefore adapted to
include an increased mass ﬂow through pyruvate carboxylase in the
glial compartment (see Appendix). In practice, using the measured
accumulation rate in glutamate (dGludt ) and in glutamine (
dGln
dt ), the
following mass balance equations were set as new constraints in the
model:
VGS  Vefflux  VGlu ¼ dGlndt
with VGS ¼ VNT þ VPC
ð4Þ
VGlu  VNT ¼ dGludt ð5Þ
where it is assumed that accumulation of glutamate and glutamine
takes place in the respective larger compartment (neuronal com-
partment for glutamate and glial compartment for glutamine)
(Storm-Mathisen et al. 1992).
With these constraints, the metabolic system is characterized by 6
independent ﬂuxes (Vg, Vx
g, VNT, Vtca
n, Vx
n, VPC).
The model was developed using Matlab (MathWorks, Natick,
MA, USA). The model was ﬁtted to the measured turnover curves,
using a standard built-in ordinary differential equation solver and a
modiﬁed Levenberg-Marquardt non-linear regression method. The
ﬁtting procedure was weighted with the square root of the inverse of
the variance of the experimental noise, in order to take into account
the different precisions in the measurement of the 4 turnover curves.
Glial glutamate fraction
In two-compartment modeling of brain metabolism, the glial and
neuronal glutamate pools are linked to their respective TCA cycle
and are therefore labeled differently. However, the proportion of the
measured total glutamate which is located in the glial compartment
cannot be assessed directly from 1H MRS. Usually, this concentra-
tion is assumed as a fraction of the total measured glutamate
(between 1.5% (Patel et al. 2010) and 14% (Gruetter et al. 2001)),
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Fig. 2 (a) Example of in vivo edited 1H-[13C] MRS
spectrum acquired at 14.1T in a 144 lL voxel
centered in cerebral cortex of a rat. The data were
averaged over 45 min, about 105 min after the
beginning of the [2–13C]acetate infusion. This
spectrum illustrates the higher spectral resolution
achieved at high magnetic ﬁeld, enabling the
separate quantiﬁcation of AceC2, GluC4, GlnC4,
GluC3, and GlnC3. See (Xin et al. 2010) for details
on this MRS acquisition method. (b) Fit of the
model presented in ﬁgure 1 to the time courses of
fractional enrichment (FE) of glutamate and
glutamine positions C4 and C3, averaged over
six rats, using the measured brain AceC2 as input
function. Glutamate enrichment curves represent
the sum of the glial and neuronal glutamate pools,
while the glutamine enrichment curves are
modeled as purely glial (see discussion). AceC2
was smoothed by ﬁtting it with a function of the
type yðtÞ ¼ ða  t þ bÞð1 ek t Þ; to take into
account the slow increase in FE measured in the
second part of the curve.
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or ﬁxed to a certain concentration (between 0.2 and 1.25 lmol/g
(Sibson et al. 2001)).
Since 13C from acetate enters through the glial TCA cycle, the
turnover curves are expected to be especially sensitive to glial
parameters. Furthermore, the glial glutamate pool is the labeling
precursor of glutamine. The early glutamate FE time points are thus
expected to reﬂect mainly the glial component of glutamate, before
the large neuronal contribution starts to dominate.
The ﬁt of the experimental data was therefore repeated for a range
of glial glutamate concentrations varying between 0.08 and
1.5 lmol/g. The weighted residual sum of squares of the ﬁt was
then calculated for each of the assumed glial concentrations. The
lowest ﬁt residual was selected as an estimate of the glial glutamate
concentration in the considered brain region. For the other parts of
our study, the glial glutamate pool size was then ﬁxed to this
optimized value.
Influence of the experimental conditions on the flux precision
To evaluate the effect of the experiment duration, the temporal
resolution and the noise level of the turnover curves on the
precision of the ﬂuxes, an extended Monte Carlo analysis was
undertaken on synthetic turnover curves. Artiﬁcial GluC4, GluC3,
GlnC4, and GlnC3 FE time courses were generated with the
differential system characterizing the model, using the ﬂux values
and metabolite concentrations obtained on the experimental data
(Vg = 0.27, Vx
g = 0.17, VNT = 0.15, Vtca
n = 0.37, Vx
n = 0.46, VPC =
0.087 lmol/g/min, [Gln] = 3.4 lmol/g and [Glu] = 11.5 lmol/g,
from which 0.6 lmol/g was assumed to be in the glial compartment).
A characteristic Gaussian noise of standard deviation
r = 0.05 lmol/g and r = 0.10 lmol/g was added to the C4 and
C3 turnover curves, respectively, as measured from the experi-
mental data (Xin et al. 2010). A typical experiment duration of
150 min and a temporal resolution of 5 min were assumed as
standard conditions.
Starting from these initial conditions, different experimental
conditions were simulated by generating the GluC4, GluC3,
GlnC4, and GlnC3 turnover curves varying either the length of the
experiment (from 60 to 450 min), the time resolution (from 1.5 to
30 min) or by varying the noise level (from 0.2 to 5 times the
original noise).
These sets of turnover curves were then ﬁtted with the neuroglial
metabolic model to obtain the best ﬁt values for Vg, Vx
g, VNT, Vtca
n,
Vx
n, and VPC, using the same minimization procedure as for the
experimental data.
Statistical analysis
The standard deviation of the ﬁtted ﬂux values reported in this
study were obtained from Monte Carlo simulations, based on ﬁts
of at least 100 artiﬁcial data (Mason and Rothman 2004). These
data are synthetic GluC4, GluC3, GlnC4, and GlnC3 enrichment
time courses, generated with the ﬂux values obtained with the
best ﬁt, to which a gaussian noise of same variance r2 than the
corresponding experimental turnover curves was added. The
initial values of the ﬂuxes were taken randomly between 0 and
1 lmol/g/min. The 95% conﬁdence interval of the optimized glial
glutamate concentration was calculated directly from the covari-
ance matrix of the adjusted parameters obtained from the non-
linear regression.
Results
To determine the precursor isotopic enrichment, plasma
samples were measured with high-resolution NMR
spectroscopy. The isotopic enrichment of AceC2 in blood
reached 95% within 5 min after starting the infusion of
[2-13C]sodium acetate and was stable at around 90% during
the whole experiment. The concentration of plasma acetate
during the experiment was 9  3 mM.
From the analysis of the unedited 1H spectra and 13C-
edited 1H spectra (64 averages), total concentration
(12C + 13C) and the concentration of 13C-labeled acetate
and metabolites were obtained. The average concentrations
obtained on the six animals were [Gln] = 3.4 lmol/g and
[Glu] = 11.5 lmol/g.
The FE of brain acetate C2, used as input function, was
reaching a ﬁrst step at 80% after 15 min. After this ﬁrst quick
increase in FE, the enrichment of acetate C2 was linearly
increasing to about 90% after 150 min.
During the infusion of sodium acetate, glutamate, and
glutamine total concentrations were increasing with a rate of
0.018 and 0.004 lmol/g/min, respectively. The two-com-
partment model was therefore adapted to include an
increased mass ﬂow through pyruvate carboxylase in the
glial compartment.
To determine the metabolic ﬂuxes from the 13C time
courses, the two-compartment model presented in Fig. 1 was
ﬁtted to the FE turnover curves of the C4 and C3 positions of
glutamate and glutamine (Fig. 2b) by adjusting the metabolic
ﬂuxes. The values of the determined metabolic ﬂuxes are
summarized in Table 1. Using brain acetate FE as input
function, the model was able to accurately describe the
measured turnover curves (R2 > 0.99). The glutamine label-
ing positions were the ﬁrst to be labeled, consistent with the
dominant glial metabolism of acetate, since most glutamate is
located in the neuronal compartment (Storm-Mathisen et al.
1992), whereas astrocytes contain most of the glutamine. The
C4 positions were more enriched both in glutamate and in
glutamine. The maximal FE reached by GlnC4 at the end of
the experiment was 34%, while GluC3, the strongest diluted
labeling position measured in this study, reached only 12%.
Glutamine had a larger difference between the enrichments
of C4 and C3 than glutamate, indicating that the glial-speciﬁc
pyruvate carboxylase, diluting speciﬁcally the position C3,
had a substantial activity compared with the glutamatergic
neurotransmission rate.
An important factor in determining the metabolic ﬂuxes is
the glial glutamate concentration. To estimate its concentra-
tion, we varied the pool size of glial glutamate from 0.08 to
1.5 lmol/g and analyzed its effect on the weighted residual
sum of squares of the ﬁt (Fig. 3). It presents an optimum for
a glial glutamate concentration of 0.6  0.1 lmol/g. A 95%
conﬁdence interval was extracted from the ﬁt statistics and
places [Glug] in the range between 0.36 and 0.82 lmol/g.
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To determine how the precision of the metabolic ﬂuxes
depends on experimental conditions, we simulated the effect
of experiment duration on the standard deviation of Vg, Vx
g,
VNT, Vtca
n, Vx
n, and VPC when varying the measurement
duration, from 60 to 450 min, and keeping a temporal
resolution of 5 min and an experimentally determined
standard noise level of 0.05 lmol/g and 0.1 lmol/g for the
C4 and C3 turnover curves, respectively (Fig. 4a). When
data were measured during less than 150 min, the neuronal
ﬂux across the mitochondrial membrane, Vx
n, was not
reliably determined anymore. The precision of Vtca
n was
reduced, evident from an increase of its relative error to 60%
for 80 min of acquisition. Above the 150 min threshold, all
the ﬁtted ﬂuxes presented a coefﬁcient of variation below
25%. The glial TCA cycle ﬂux Vg and the neurotransmission
ﬂux VNT were throughout well determined (coefﬁcient of
variation of about 10%), even when a shorter experiment
duration of less than 100 min was used.
When evaluating the inﬂuence of temporal resolution at a
ﬁxed experiment duration of 150 min and a noise level of
0.05 lmol/g and 0.1 lmol/g for the C4 and C3 turnover
curves, respectively, we noted that the estimated value for the
neuronal transmitochondrial ﬂux Vx
n diverged for a temporal
resolution lower than one measurement every 15 min
(Fig. 4b). For the other metabolic ﬂuxes, the reduction in
temporal resolution resulted in a progressive deterioration of
their precision with a maximal coefﬁcient of variation of 55%
for the glial transmitochondrial ﬂux Vx
g at a temporal
resolution of 30 min.
The effect of the noise level of the turnover curves was
analyzed by multiplying the experimentally determined noise
level (0.05 lmol/g for the C4 positions and 0.1 lmol/g for
the C3 positions) by a noise factor N, varying between 0.2
and 5 (Fig. 4c). The transmitochondrial ﬂuxes Vx
g and Vx
n
were the most sensitive to the noise level. With more than a
twofold increase in the noise level, the relative standard
deviation of Vx
g and Vx
n became higher than 100%, which
made their determination unreliable (Fig. 4c). Vx
n diverged
already for a noise factor of 1.5 (0.075 lmol/g for the C4
positions and 0.15 lmol/g for the C3 positions). The glial
and neuronal TCA cycle ﬂuxes and the neurotransmission
ﬂux as well as the pyruvate carboxylase ﬂux were progres-
sively losing precision with the increase of the experimental
noise, without presenting a critical point above which their
uncertainties would suddenly increase. As observed for the
experiment duration and the temporal resolution (see above),
the glial TCA ﬂux Vg and the neurotransmission ﬂux VNT
were the most reliable ﬂuxes determined with two-compart-
ment modeling when infusing [2–13C]acetate, with errors
below 70% and 40%, respectively, for a noise factor of 5
(0.25 lmol/g for the C4 positions and 0.5 lmol/g for the C3
positions).
Discussion
In this study, we extended the sensitivity of detection and
temporal resolution of the 13C turnover curves of glutamate
and glutamine under infusion of [2-13C]acetate using a
recently developed 1H-[13C] MRS localized detection
Table 1 Determined metabolic ﬂuxes (lmol/g/min) with reference to the model shown in ﬁgure 1. The errors were determined by Monte Carlo
simulation, based on 500 artiﬁcial data sets, using experimentally determined noise levels for the synthetic glutamate and glutamine enrichment
curves
Adjusted metabolic ﬂuxes (in lmol/g/min)
Vg Vx
g VPC VNT Vtca
n Vx
n
0.27  0.02 0.17  0.02 0.087  0.012 0.15  0.01 0.37  0.06 0.46  0.05
Derived metabolic ﬂuxes (in lmol/g/min)
VGS Vtca
g Vefﬂux VGlu
0.24  0.02 0.36  0.03 0.065  0.018 0.17  0.01
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Fig. 3 Evolution of the residual sum of squares with the assumed glial
glutamate concentration. The ﬁt error function was scaled with respect
to the best ﬁt residual sum of squares, which was found for a glial
glutamate concentration of 0.6 lmol/g. Mathematically, this curve
represents an orthogonal projection of the residual sum of squares
function from the parameter space on the one-dimensional subspace
of the glial glutamate concentration. A 95% conﬁdence interval was
estimated from the covariance matrix of the regression when adding
glial glutamate concentration as a free parameter.
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method at high magnetic ﬁeld (14.1T). This detection method
takes advantage of the higher spin polarization and spectral
resolution obtained at 14.1T as well as the stronger
gyromagnetic ratio of 1H, as compared to 13C. This technique
enabled the measurement of the 13C turnover curves of
glutamate and glutamine at position C4 and C3 as well as of
acetate at position C2 with a temporal resolution of 4.5 min
in a 144 lL voxel. The position C3 of glutamate and
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Fig. 4 Analysis of the precision in the determination of the glial (Vg,
Vx
g, and VPC) and neuronal (Vtca
n, Vx
n, and VNT) metabolic ﬂuxes as a
function of the noise level, duration, and temporal resolution of the
acquired labeling data. (a) Variation of the relative standard deviation
of the 6 ﬁtted metabolic ﬂuxes with the experiment duration. This
simulation was based on the ﬁt of the 4 turnover curves (GluC4, GlnC4,
GluC3, GlnC3), with a temporal resolution Dt of 5 min and a typical
noise level of rC4 = 0.05 lmol/g for the C4 positions and
rC3 = 0.1 lmol/g for the C3 positions of glutamate and glutamine.
(b) Variation of the relative standard deviation of the 6 ﬁtted metabolic
ﬂuxes with the temporal resolution. This simulation was based on the ﬁt
of the 4 turnover curves (GluC4, GlnC4, GluC3, GlnC3), with an
experimental duration Texp of 150 min and a typical noise level of
rC4 = 0.05 lmol/g for the C4 positions and rC3 = 0.1 lmol/g for the
C3 positions of glutamate and glutamine. (c) Variation of the relative
standard deviation of the 6 ﬁtted metabolic ﬂuxes with the noise level.
This simulation was based on the ﬁt of the 4 turnover curves (GluC4,
GlnC4, GluC3, GlnC3), with an experimental duration Texp of 150 min
and a temporal resolution Dt of 5 min. The noise level (in lmol/g) is
equal to the noise factor multiplied with a standard noise of
rC4 = 0.05 lmol/g for the C4 positions and rC3 = 0.1 lmol/g for the
C3 positions of glutamate and glutamine.
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glutamine could be measured separately and used in the
metabolic modeling for the ﬁrst time in an in vivo 13C-acetate
infusion experiment. From the two-compartment modeling of
these uptake curves, a precise determination of the glial and
neuronal TCA cycle ﬂuxes, glial pyruvate carboxylase, as
well as the apparent neurotransmission ﬂux characterizing
the neuroglial glutamate-glutamine exchange was possible.
Moreover, based on the C3 enrichment curves, we could
extend the metabolic modeling to measure separately the
glial and neuronal transmitochondrial ﬂuxes. Monte Carlo
analysis demonstrated that the 6 adjusted metabolic ﬂuxes
are determined with high precision, with a maximal error of
16% for the neuronal TCA cycle ﬂux (Vtca
n). In addition, we
estimated a glial glutamate concentration of 0.6 lmol/g by
minimization of the weighted residual sum of squares when
varying the neuroglial distribution of the total measured
glutamate.
Metabolic fluxes
The measurement of the C3 positions of glutamate and
glutamine is particularly challenging in 13C-acetate infusion
experiments, since the large dilution of glutamate through
the neuronal TCA cycle reduces considerably the FE of the
turnover curves, compared to glucose infusion experiments.
In the case of the C3 positions, a maximum FE of 20% was
reached for GlnC3 at the end of the acquisition. This overall
lower 13C signal is a strong argument toward the use of the
more sensitive indirect 13C detection (de Graaf et al.
2003b). However, the lower spectral resolution of this
method makes the separation of glutamate and glutamine C3
peaks difﬁcult. Nevertheless, the higher magnetic ﬁelds
NMR scanners as well as the improved shimming method-
ologies available today enable a reliable separation of these
peaks (Xin et al. 2010), with a temporal resolution of about
4.5 min.
Glial Vg was 0.27  0.02 lmol/g/min, which corresponds
to more than half of the neuronal TCA cycle rate, supporting
the signiﬁcant role of glial resting oxidative metabolism
(Danbolt 2001; Dienel 2011; Hertz 2011).
One goal of this study was to assess the transmitochondrial
rate Vx, representing the exchange between cytosolic gluta-
mate and 2-oxoglutarate in the TCA cycle, located in the
mitochondrial matrix. This exchange is principally mediated
by the malate-aspartate shuttle (Gruetter et al. 2001). Vx is in
fact a composite representation of glutamate dehydrogenase,
aspartate transaminase and transport across the membrane of
the mitochondria. In previous studies, Vx was frequently
assumed to be much larger than the TCA cycle rate Vtca
(Hyder et al. 1996; Sibson et al. 1998; de Graaf et al.
2003a), as suggested by early results (Mason et al. 1992,
1995). This assumption leads to the fact that the labeling
patterns of 2-oxoglutarate and glutamate follow each other
without time lag, in both glial and neuronal compartments,
which allows for simpliﬁcation in the metabolic model but
may lead to underestimation of the TCA cycle ﬂuxes
(Uffmann and Gruetter 2007).
The determination of the transmitochondrial ﬂuxes
requires the measurement of the C3 turnover curves of
glutamate and glutamine, which are especially sensitive to
the transmitochondrial ﬂuxes in the early part of the
experiment (Henry et al. 2006). The measurement of the
C4 positions only allows the assessment of the composite
ﬂux Vgt (Vgt ¼ VxVtcaVxþVtca)(Uffmann and Gruetter 2007), while
assumptions have to be made on the value of the respective
Vx. Several studies showed that the transmitochondrial ﬂux is
in the same order of magnitude than Vtca (Gruetter et al.
2001; Choi et al. 2002; Henry et al. 2002; Oz et al. 2004;
Duarte et al. 2011). However, Vx was typically measured
with a relatively poor precision, on the order of 30% or more.
In this study, we could determine both glial and neuronal
transmitochondrial ﬂuxes Vx
g and Vx
n with a precision of
< 12%. Both ﬂuxes were on the same order of magnitude as
the corresponding TCA cycle ﬂuxes. This result is in very
good agreement with previous in vivo 13C glucose infusion
study (Duarte et al. 2011) and is supported by recent 13C
glucose labeling studies in cultured astrocytes (Amaral et al.
2011) and in vivo 13C-acetate MRS studies using dynamic
polarization techniques (Mishkovsky et al. 2012). The use of
the glial-speciﬁc 13C-acetate substrate enabled the determi-
nation of Vx
g with an increased precision, compared to
labeled glucose infusion studies.
In the glial compartment, the measured transmitochondrial
ﬂux Vx
g is signiﬁcantly smaller than the TCA cycle ﬂux
VTCA
g (VTCA
g = Vg+VPC is the pyruvate dehydrogenase ﬂux
in the glial compartment), coherent with previous 13C
glucose labeling studies (Duarte et al. 2011). The glial
malate-aspartate shuttle represented by Vx
g participates to the
cytosolic NADH/NAD+ balance required for the glycolysis
in the glial compartment (Hertz et al. 2007), which produces
pyruvate, a TCA cycle substrate. This observation supports
the fact that the glial TCA cycle is fueled in a signiﬁcant
proportion by substrates which do not require reducing
equivalent transport, such as acetate and fatty acids (Hertz
et al. 2007).
Interestingly, although acetate is not a substrate of the
pyruvate carboxylation pathway, it was possible to determine
a pyruvate carboxylase ﬂux VPC = 0.087  0.012 lmol/g/
min. This was possible since pyruvate carboxylase dilutes
speciﬁcally the position C3 of glial glutamate, while the
position C4 remains unaffected (Fig. 1b). At steady-state, the
FE of glutamine reaches the level of its direct precursor, glial
glutamate. The effect of pyruvate carboxylase can be
qualitatively observed by the C4 to C3 enrichment ratio
being higher in glutamine than in glutamate at the end of the
experiment. Although part of this difference could be
explained by a higher Vx/Vtca ratio in the glial compartment
than in the neuronal one, the metabolic model was unable to
fully describe the dynamics of the 4 uptake curves without
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the inclusion of the pyruvate carboxylase ﬂux (data not
shown). VPC accounts for 37% of the rate of glutamine
synthesis, a higher fraction than what has been recently
reported in the human brain (Mason et al. 2007), but in good
agreement with previous measurements in humans and in the
anesthetized or awake rat brain (Gruetter et al. 2001; Sibson
et al. 2001; Oz et al. 2004; Duarte et al. 2011). The value
found for the pyruvate carboxylase ﬂux under infusion of
[2-13C2]acetate was 26% higher than the value found under
[1,6-13C2]glucose infusion (Duarte et al. 2011), consistent
with the slow increase of mass in the glutamate and
glutamine pools when infusing sodium acetate.
Overall, the values found for the different ﬂuxes are in
very good agreement with the values found in previous
[1,6-13C2]glucose infusion studies (Duarte et al. 2011) and
with the values recently found using [1-11C]acetate infusion
in positron emission studies in rats (Lanz et al. 2012)
(Table 2). Compared to glucose infusion studies, fewer
labeling curves (GluC4, GlnC4, GluC3, and GlnC3) were
needed to achieve similar or better precision on the glial
metabolic ﬂuxes or the neurotransmission rate.
Effect of glutamate and glutamine pool distribution
To determine the inﬂuence of differential distribution of
glutamine (predominantly glial) and glutamate (predomi-
nantly neuronal), we analyzed the sensitivity of the gluta-
mate and glutamine uptake curve to these assumptions.
Replacing the glial glutamine and neuronal glutamine pools
by a single kinetic compartment had a negligible effect on
the dynamics of the turnover curves and, consequently, on
the derived metabolic ﬂuxes (data not shown). This can be
understood by the fact that glutamine participates in only
two biochemical reactions, namely glutamine synthesis in
the glia (VGS) and the phosphate-activated glutaminase
(PAG) in neurons, in contrast to glutamate. The large glial
glutamine pool is the only precursor of the neuronal
glutamine pool, which is only a small fraction of total
glutamine (Storm-Mathisen et al. 1992). The labeling
dynamics of neuronal glutamine is therefore much faster
than glial glutamine and the neuronal pool is basically
following the enrichment of its precursor, which results in
very similar FEs in both glutamine pools.
It is well established that tissue glutamate in brain is
unequally distributed between the neuronal and glial compart-
ments (Storm-Mathisen et al. 1992). In early studies, the
presence of two distinct glutamate pools was proposed from
14C labeling studies inmice (vandenBerg andGarﬁnkel 1971),
reporting a small glutamate pool with a concentration of
1.3 lmol/g and a large neuronal pool of 7 lmol/g. Using
immunochemical methods (Ottersen et al. 1992; Storm-Math-
isen et al. 1992), it was found that most of glutamate is in the
neuronal compartment, while glutamine is mostly located in
astrocytes. A glutamate to glutamine ratio of 0.2 in astrocytes
was reported,which is in good agreementwith the values found
in our study, if all glutamine is assumed to be in the glial
compartment (0.6 lmol/g for Glug with 3.4 lmol/g of Gln).
The dilution from pyruvate metabolism at the level of glial
acetyl-CoA, represented by Kdil [Fig. 1a and Appendix,
eqns (8) and (9)], could be theoretically extracted from the
steady-state enrichment of the glutamine labeling positions.
However, when ﬁtting the model and including Kdil as free
parameter, the value found for Kdil was subject to high
uncertainty and was strongly correlated with the glial TCA
cycle ﬂux and transmitochondrial ﬂux (data not shown). In the
case of acetate infusion, Kdil is expected to be at least as high as
the value found with glucose infusion [0.76 in (Duarte et al.
2011)], because of higher amount of available plasma acetate.
A 10% increase in Kdil resulted in a decrease of 11% and 35%
in Vg and Vx
g, respectively, while all the other ﬂuxes and the
determined glial glutamate concentration were marginally
affected (< 4%). The conclusions of this study are therefore not
affected by the assumption on glial acetyl-CoA dilution.
The transport of acetate across the blood-brain barrier
(BBB) may be rate-limiting, however, the acetate infusion of
our experiments resulted in a step-wise increase in plasma
acetate concentration to 9 mM, where transport across the
BBB was shown not to be rate-limiting for metabolism
(Deelchand et al. 2009b). Note that in this study, we used the
NMR-measured brain acetate 13C enrichment as direct input
to the metabolic system, which minimizes the impact of
acetate transport on the metabolic ﬂux determination.
The metabolic model used for [2-13C]acetate labeling
studies is based on the assumption of the purely glial uptake
and metabolism of acetate (Lebon et al. 2002; Deelchand
Table 2 Comparison of the determined metabolic ﬂuxes (lmol/g/min) obtained infusing 13C-acetate, 13C-glucose (Duarte et al. 2011) or
11C-acetate (Lanz et al. 2012), a positron emitting radiotracer
Brain metabolic ﬂuxes (in lmol/g/min) obtained with different labeled substrates
Substrate Vg Vx
g VPC Vgt
g VNT Vtca
n Vx
n Vgt
n
[2-13C]acetate 0.27  0.02 0.17  0.02 0.09  0.01 0.17  0.01 0.15  0.01 0.37  0.06 0.46  0.05 0.21  0.02
[1,6-13C2]glucose
a 0.23  0.02 0.17  0.06 0.07  0.01 0.15  0.02 0.12  0.01 0.44  0.01 0.76  0.07 0.28  0.01
[1-11C]acetateb – – – 0.14  0.04 0.17  0.10 – – –
a(Duarte et al. 2011).
b(Lanz et al. 2012).
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et al. 2009b; Patel et al. 2010). At low plasma level, acetate is
known to be transported primarily into glial cells (Waniewski
and Martin 1998). At higher plasma acetate concentrations as
used for in vivo studies, the passive diffusion of acetate through
the cell membrane and its metabolism through acetate
thiokinase both in the glial cells and the neurons could be
possible. However, several previous 13C-acetate infusion
studies showed evidences for the predominantly glial uptake
and metabolism, even at higher plasma acetate levels (Badar-
Goffer et al. 1990; Hassel et al. 1995). At the end of our
labeling experiment, the FE of glutamate C4 reached 15%,
while glutamine C4 FE was about 35%. Since about 90% of
glutamate is located in the neuronal compartment, the gluta-
mate C4 enrichment curve represents essentially the neuronal
glutamate C4 pool. The large difference between the FE of
neuronal glutamate and its precursor in the glutamate/gluta-
mine cycle indicates a strong dilution of neuronal glutamate
through transmitochondrial exchange with the neuronal TCA
cycle and supports the fact that neurons metabolize predom-
inantly other substrates than acetate, even at relatively high
plasma acetate concentrations. Moreover, based on previously
measured metabolic ﬂuxes (Duarte et al. 2011) and the FE of
Glu C4 andGln C4 obtained in the near steady-state conditions
at the end of the experiment, the FE of the neuronal acetyl-CoA
was estimated to be lower than 5%, which conﬁrms that in our
experimental conditions, acetate is not or marginally used as
substrate by neurons.
When infusing [2-13C]sodium acetate, we observed an
increase of about 20% over 3 hours both in the total glutamate
and total glutamine concentrations, consistent with previous in
vivo studies (Chowdhury et al. 2007; Deelchand et al. 2009b;
Patel et al. 2010), which could be related to an osmotic effect
induced by the infusion of sodium acetate, as previously
discussed (Deelchand et al. 2009b; Patel et al. 2010). The
metabolic model was adapted to take into account the increase
in pool size by assuming that new carbon chains are
synthesized via pyruvate carboxylase. Note that the measured
accumulation of glutamate and glutamine over 150 min,
although statistically signiﬁcant, was modest (24% for gluta-
mate and 16% for glutamine) and did not affect signiﬁcantly
the dynamics of brain metabolism, since the measured ﬂuxes
are in good agreement with the metabolic ﬂuxes obtained with
13C labeled glucose infusion, where no signiﬁcant change in
amino acid concentration was measured (Table 2). Brain
metabolicﬂuxes determinedwith two-compartmentmodeling,
and in particular the transmitochondrial ﬂuxes Vx
g and Vx
n, are
thus largely independent on the substrate used.
To determine the consequence of the mass increase in
glutamate and glutamine on the modeling results, we adjusted
the metabolic model to the measured curve, assuming constant
glutamate and glutamine total concentrations, equal to their
respective average value over the entire infusion time. With
this assumption, the neuronal TCA cycle ﬂux was 20%
smaller, while Vx
g and VPC were, respectively, increased by
40% and decreased by 50%. The changes in the remaining
metabolic ﬂuxes were within 10%. As a consequence, the
increase in glutamate and glutamine pool sizes appears to be an
important aspect to take into account in the metabolic model to
avoid biased determination of the metabolic ﬂuxes.
Recent studies indicated that astrocytic energy metabolism
is more intense as previously believed, suggesting a major
involvement of glial cells in functional activities. 14C-acetate
autoradiography experiments showed that the TCA cycle
activity increases in astrocytes during acoustic or visual
stimulations (Dienel and Hertz 2001; Cruz et al. 2005),
indicating that astrocytic respiration can be up-regulated by
signaling mechanisms. The glial-speciﬁc pyruvate carboxyl-
ation increases during some but not all stimulations, while
pathological conditions might also activate glial oxidative
demand (Hertz et al. 2007). It remains also unclear if glial
glutamate oxidation changes during activation in vivo. There
are therefore many motivations to develop quantitative in
vivo metabolic studies such as the presented 13C-acetate
MRS approach, to better understand the particular role of
astrocytic metabolism in brain function.
Conclusion
We conclude that when using [2-13C]acetate, two-compart-
ment modeling of the C4 and C3 labeling curves of glutamate
and glutamine obtained with 1H-[13C] MRS enables the
measurement of mitochondrial metabolism both in the glial
and neuronal compartment in vivo. In particular, the predom-
inant glial uptake of acetate allows a precise determination of
the glial metabolic ﬂuxes and the apparent glutamatergic
neurotransmission rate. In this study, the transmitochondrial
exchange rates between glutamate and 2-oxoglutarate were
determined separately for the glial and neuronal compart-
ments, based on the analysis of the C3 uptake curves of
glutamate and glutamine measurable at high magnetic ﬁeld.
Moreover, we provided the ﬁrst in vivo estimation of the glial
glutamate pool size in the rat brain tissue. 13C-acetate infusion
studies are therefore an attractive alternative to themorewidely
used 13C-glucose infusions for studying pathological or
physiological alterations of glial oxidative metabolism.
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Appendix
The mathematical model of compartmentalized cerebral
metabolism was adapted from (Gruetter et al. 2001), where
the reader can ﬁnd an exhaustive description of the model.
The metabolic pools and ﬂuxes of the considered model are
represented in Fig. 1. Metabolic steady-state was assumed for
the metabolic ﬂuxes (constant) and the metabolic pools except
glutamine and the major neuronal glutamate pools, which
total concentration was slightly increasing over time, as
measured by 1H MRS. The in vivo measured mean glutamate
and glutamine concentrations were 11.5 and 3.4 lmol/g,
respectively. As determined in this study, 0.6 lmol/g of
glutamate was contained in the glial compartment, while all
the glutamine was assumed to be glial.
The non-steady-state conditions for glutamine and neuro-
nal glutamate was modeled using the following mass-balance
equations. dGlu/dt and dGln/dt are the slopes of the increase
in total glutamate and total glutamine concentrations,
respectively, as measured by 1H MRS:
VGS  Vefflux  VGlu ¼ dGlndt
with VGS ¼ VNT þ VPC
ð6Þ
VGlu  VNT ¼ dGludt ð7Þ
The mass balance relations shown in eqns (6) and (7) were
further used as constraints in the metabolic model, i.e. VNT
and VPC are adjusted in the ﬁtting of the
13C turnover curves,
while Vefﬂux, VGlu, and VGS are then determined from
eqns (6) and (7).
Transport of acetate across the blood–brain barrier was not
modeled, as brain acetate FE was directly measured with
1H-[13C] MRS and used as input function for the model.
Glial compartment
Pyruvate and acetate compete for the generation of acetyl-
CoA:
The position 2 of glial acetyl-CoA is labeled as follows:
dAcCoAg2
dt
¼ VAce
Ace2ðtÞ
Ace
 VAce þ Vgdil
 AcCoAg2ðtÞ
AcCoA
ð8Þ
whereVAce is thenetmetabolicﬂuxofacetate toacetyl-CoAand
Vgdil is the dilution ﬂux from the metabolism of unlabeled
pyruvate in the glial compartment.Workingwith the small pool
approximation for glial acetyl-CoA (Uffmann and Gruetter
2007) (dAcCo
g
2
dt ﬃ 0very early comparedwith the large glutamate
pool), we obtain the following relationship between the
fractional enrichment of AcCoAg2 and plasma Ace2:
AcCoAg2ðtÞ
AcCoA
¼ VAce
VAce þ Vgdil
  Ace2ðtÞ
Ace
 Kdil Ace2ðtÞAce ð9Þ
Kdil represents the afﬁnity of glial cells to acetate as
metabolic fuel. It was ﬁxed to the value found with 13C NMR
in a recent study (Duarte et al. 2011), Kdil = 0.76.
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Further metabolism of acetate in the glial compartment is
characterized by the glial TCA cycle ﬂux Vg, the transmi-
tochondrial exchange between 2-oxoglutarate and glutamate
Vx
g and pyruvate carboxylase VPC.
In the glial TCA cycle, the labeling of 2-oxoglutarate is
given by the following equations:
dOGg4
dt
¼KdilðVgþVPCÞAce2ðtÞAce þV
g
x
Glug4ðtÞ
Glug
ðVgx þVPCþVgÞ
OGg4ðtÞ
OGg
ð10Þ
dOGg3
dt
¼Vg
2
OGg4ðtÞ
OGg
þVgx
Glug3ðtÞ
Glug
 Vgx þVPCþ
Vg
2
 
OGg3ðtÞ
OGg
ð11Þ
The factor ½ appearing in eqn (11) is related to the fact
that in each TCA cycle turn, half of the labeling from OG4
g
goes to OG3
g and half of it goes to OG2
g, because of the
symmetry of the succinate molecule (Uffmann and Gruetter
2007). Similarly, half of the labeling from OG3
g goes to
OG2
g and half of it comes back to OG3
g.
The labeling of glial glutamate is given by the following
equations:
dGlug4
dt
¼ Vgx þ VPC
 OGg4ðtÞ
OGg
þ VNT Glu
n
4ðtÞ
GlunðtÞ  ðV
g
x þ VGSÞ
Glug4ðtÞ
Glug
ð12Þ
dGlug3
dt
¼ Vgx þ VPC
 OGg3ðtÞ
OGg
þ VNT Glu
n
3ðtÞ
GlunðtÞ
 ðVgx þ VGSÞ
Glug3ðtÞ
Glug
ð13Þ
Removing the (non-measurable) TCA cycle intermediates
from the model
We made use of a simpliﬁcation of the metabolic model by
removing the TCA cycle intermediates from the labeling
equations, as suggested in previous studies (Uffmann and
Gruetter 2007; Duarte et al. 2011). This results in mathe-
matical expressions which do not contain non-measurable
metabolic pools, while the effect of the simpliﬁcation on the
determined metabolic ﬂuxes is marginal.
By injecting in eqn (12) the expression of OG
g
4
OGg isolated in
eqn (10), we obtain the following:
dGlug4
dt
¼ðVgx þVPCÞ
"
KdilðVgþVPCÞ
ðVgx þVPCþVgÞ
Ace2ðtÞ
Ace
þ V
g
x
ðVgx þVPCþVgÞ
Glug4ðtÞ
Glug
 1ðVgx þVPCþVgÞ
dOGg4
dt
#
þVNT Glu
n
4ðtÞ
GlunðtÞðV
g
x þVGSÞ
Glug4ðtÞ
Glug
ð14Þ
dGlug4
dt
þ V
g
x þ VPC
 
Vgx þ VPC þ Vg
  dOGg4
dt
¼
Kdil Vg þ VPC
 
Vgx þ VPC
 
Vgx þ VPC þ Vg
  Ace2ðtÞ
Ace
þ V
g
x V
g
x þ VPC
 
Vgx þ VPC þ Vg
  Glug4ðtÞ
Glug
þ VNT Glu
n
4ðtÞ
GlunðtÞ
 ðVgx þ VGSÞ
Glug4ðtÞ
Glug
ð15Þ
In the small pool approximation, we assume that the
increase in glutamate enriched carbons is much larger than
the increase in 2-oxoglutarate 13C concentration, i.e.
dOGg4
dt 
dGlug4
dt . This approximation is as much better that the
time after the start of the infusion gets larger, since the small
pool reaches its labeling steady-state faster than the larger
pool. The small pool approximation leads to the following
expression for the labeling of glial glutamate C4, in which
the TCA cycle intermediate pools vanished:
dGlug4
dt
¼
Kdil Vg þ VPC
 
Vgx þ VPC
 
Vgx þ VPC þ Vg
  Ace2ðtÞ
Ace
þ V
g
x V
g
x þ VPC
 
Vgx þ VPC þ Vg
  Glug4ðtÞ
Glug
þ VNT Glu
n
4ðtÞ
GlunðtÞ
 ðVgx þ VGSÞ
Glug4ðtÞ
Glug
ð16Þ
Using the same strategy for glial glutamate C3, we obtain
the following expression:
dGlug3
dt
¼
Kdil Vg þ VPC
 
Vgx þ VPC
 
Vgx þ VPC þ Vg
Vg
2Vgx þ 2VPC þ Vg
	 Ace2ðtÞ
Ace
þ Vg V
g
x þ VPC
 
Vgx þ VPC þ Vg
Vgx
2Vgx þ 2VPC þ Vg
	 Glu
g
4ðtÞ
Glug
þ Vgx
Vgx þ VPC
Vgx þ VPC þ Vg2
  Glug3ðtÞ
Glug
þ VNT Glu
n
3ðtÞ
GlunðtÞ  ðV
g
x þ VGSÞ
Glug3ðtÞ
Glug
ð17Þ
Neuronal compartment
Acetate is considered not to be metabolized in the neuronal
compartment. Pyruvate carboxylase is also absent in the
neurons. 13C is therefore entering the neuronal TCA cycle
through its interaction with the neuronal glutamate pool. In
the neuronal compartment, the labeling of the TCA interme-
diates and the neuronal glutamate pools is given by:
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dOGn4
dt
¼ Vnx
Glun4ðtÞ
GlunðtÞ  V
n
x þ Vntca
 OGn4ðtÞ
OGn
ð18Þ
dOGn3
dt
¼ V
n
tca
2
OGn4ðtÞ
OGn
þ Vgx
Glun3ðtÞ
GlunðtÞ  V
n
x þ
Vntca
2
 
OGn3ðtÞ
OGn
ð19Þ
dGlun4
dt
¼ Vnx
OGn4ðtÞ
OGn
þ VGlu Gln4ðtÞGlnðtÞ  ðV
n
x þ VNTÞ
Glun4ðtÞ
GlunðtÞ
ð20Þ
dGlun3
dt
¼ Vnx
OGn3ðtÞ
OGn
þ VGlu Gln3ðtÞGlnðtÞ  ðV
n
x þ VNTÞ
Glun3ðtÞ
GlunðtÞ
ð21Þ
Using the same approach as for the glial glutamate pools, the
TCA cycle intermediates can be eliminated from the
differential equations describing the labeling of the neuronal
glutamate pools:
dGlun4
dt
¼Vnx
Vnx
Vnx þVntca
  Glun4ðtÞ
GlunðtÞ
þVGlu Gln4ðtÞGlnðtÞ  ðV
n
x þVNTÞ
Glun4ðtÞ
GlunðtÞ
ð22Þ
dGlun3
dt
¼ V
n
tcaV
n
x
Vnx þ Vntca
Vnx
2Vnx þ Vntca
Glun4ðtÞ
GlunðtÞ
þ Vnx
Vnx
Vnx þ V
n
tca
2
  Glun3ðtÞ
GlunðtÞ þ VGlu
Gln3ðtÞ
GlnðtÞ
 ðVnx þ VNTÞ
Glun3ðtÞ
GlunðtÞ
ð23Þ
Glutamate-glutamine cycle
The glutamate-glutamine cycle comprises the glutamine
synthesis in the glial compartment, the transfer of glutamine
to neurons where it is converted back to glutamate and stored
in the large neuronal glutamate pool and ﬁnally the
glutamatergic neurotransmission where glutamate is released
from the neurons and taken up by the glial compartment. The
labeling equations of glutamine, modeled as a single large
glial pool, are as follows:
dGln4
dt
¼ VGS Glu
g
4ðtÞ
Glug
 ðVefflux þ VGluÞGln4ðtÞGlnðtÞ ð24Þ
dGln3
dt
¼ VGS Glu
g
3ðtÞ
Glug
 ðVefflux þ VGluÞGln3ðtÞGlnðtÞ ð25Þ
where Vefﬂux accounts for the label loss through glutamine
dilution. VGS, Vefﬂux, and VGlu are modeled to take into
account the non-steady-state concentrations of glutamate and
glutamine measured under sodium acetate infusion. They are
coupled withVNT by the eqn (6) and (7) where the increase of
glutamate and glutamine, measured by 1H MRS is used in the
mass balance equations. Therefore, when ﬁtting the 13C
enrichment curves, only one degree of freedom is adjusted
for the glutamate-glutamine cycle, namely VNT, while VGS,
Vefﬂux and VGlu are determined from the mass balance
equations.
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